Weight Loss and Obesity Management Market Trends

Weight Loss and Obesity Management Market Trends

• Advances in surgical techniques and improved safety profiles are leading to an increased acceptance for surgical interventions among extremely obese patients. Availability of advanced surgical options such as biliopancreatic diversion with duodenal switch, and single anastomosis duodenal switch have revolutionized bariatric surgeries. Growing popularity of these procedures can be attributed to their enhanced effectiveness and reduced risk of weight regain, which is contributing to an increasing growth in the weight loss and obesity management market.
   
• The use of digital health technologies, encompassing mobile applications, wearable devices, and online platforms is becoming more prevalent in the field of weight management. These innovative tools provide a range of features, including calorie tracking, meal planning, fitness monitoring, behavior modification support, and remote coaching.
   
• Increasing availability of prescription medication for obesity treatment is also driving their adoption worldwide. By March 2023, U.S. FDA has approved 5 prescription medications including orlistat, phentermine-topiramate, naltrexone-bupropion, liraglutide, and semaglutide for long term use. Later, in November 2023, Mounjaro, a new drug to treat diabetes was also approved by U.S. FDA for use in weight loss. Along with existing GLP-1 receptor agonist, increasing availability of new obesity treatment drugs are offering lucrative growth opportunities to the pharmaceutical companies globally.